Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Classement en actions #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Prix de l'action
$1.05
Capitalisation boursière
$25.12M
Changement (1 jour)
0.00%
Changement (1 an)
-86.83%
Pays
US
Échange Actuate Therapeutics Inc (ACTU)

Catégorie

Historique du prix de l'action pour Actuate Therapeutics Inc (ACTU)
Prix de clôture le plus élevé : $1.04 le 2026-08-01

Prix de clôture le plus bas : $8.39 le 2024-08-01
Historique du prix de l'action de Actuate Therapeutics Inc de 2024 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -36.39%
2025 -14.02%
2024 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH